MYLK and pulmonary arterial hypertension: The crux of persistent vasoconstriction associated with PAH is based on the increased activation of smooth muscle myosin, and which is determined by the balance of the activities of myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) (Gong et al., 1992).